Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) - Clinical Trial NCTNCT05489211

Business Opportunities for NCT05489211

Connect with principal investigators, study coordinators, and key decision makers for this PHASE2 trial studying investigational therapy for Endometrial Neoplasms, Biliary Tract Neoplasms.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Endometrial Neoplasms, Biliary Tract Neoplasms

Study Phase

PHASE2

Study Status

RECRUITING

NCT Number

NCTNCT05489211

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has 95 locations across United States, Canada, China, France, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Switzerland, Taiwan, Turkey, United Kingdom.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships